- Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
-
Hibi T, Imai Y, Murata Y, Matsushima N, Zheng R, Gasink C
- KMID: 2396397
- Intest Res.
- 2017 Oct;15(4):475-486.
- doi: 10.5217/ir.2017.15.4.475
BACKGROUND/AIMS: Efficacy and safety of ustekinumab were evaluated in a Japanese subpopulation with moderately to severely active Crohn's disease (CD) in UNITI-1, UNITI-2 and IM-UNITI studies and results were compared... -
- CITED
-
- Close
- SHARE
-
- Close
